Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Aug 28, 2026

GDTC — CytoMed Therapeutics Limited Dilution Risk Tracker

Track GDTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GDTC — Get alerts when the score changes →

As of August 28, 2026, CytoMed Therapeutics Limited (GDTC) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. CytoMed Therapeutics Limited has a market capitalization of $13.84M, 11.83M shares outstanding, 3 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
77
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.02 approaching $1 threshold
🔔 Track GDTC — Get forecast alerts →

Market Data

Market Cap$13.84M
Shares Outstanding11.83M
Float1.84M
Cash$1.64M
Debt$378.1K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 69.2% shares (2026Q1 vs prior)
3 institutional holders · 16.3K shares
#1 XTX Topco Ltd 10.1K shares
#2 UBS Group AG 6.2K shares
#3 OSAIC HOLDINGS, INC. 21 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.7K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track GDTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GDTC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GDTC
GDTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.